Jaguar Health Announces Submission of Clinical Trial Applications for Crofelemer for the Rare Disease Indications ...
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency for both MVID and SBS SAN FRANCISCO, CA / ACCESSWIRE / May 9, 2024 / Jaguar Health, Inc.(NASDAQ: …